Magazine Article | December 1, 2021

Sterile Injectable Product And CMO Volume

Source: Life Science Leader

By Industry Standard Research

ISR asked respondents responsible for sterile injectable manufacturing outsourcing about the numbers and types of outsourced compounds they have in development and in marketing or foresee themselves having in five years. Overall, respondents anticipate having one additional small molecule sterile injectable product on the market within the next five years. Rates were on par for marketed biologic products, which are also predicted to increase by one product over the next five years.

VIEW THE MAGAZINE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Life Science Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: